Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice
Figure 2
Mice have High Concentrations of Bevirimat in Plasma 0.5–1 h after Oral Administration.
Serial plasma samples were collected after the final dose from SCID-hu Thy/Liv mice that had been treated with 100 mg/kg per day for 21 days. Mean±SEM for four mice.